Viewing Study NCT06332092

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2026-06-15 @ 10:01 AM
Study NCT ID: NCT06332092
Status: RECRUITING
Last Update Posted: 2025-08-28
First Post: 2024-03-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma
Sponsor: Fulgent Pharma LLC.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None FID-007 View
None Cetuximab View
None Paclitaxel View
None Head and Neck View
None p16 View